2JEMAL A,TIWARI R C,MURRAY T,et al.Cancer statistics[J].CA Cancer J Clin,2004,54:8-29.
3BERCHUCK A,RODRIGUEZ G C,KAMEL A,et al.Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer.Ⅱ.Correlation of receptor expression with prognostic factors in patients with ovarian cancer[J].Am J Obstet Gynecol,1991,164:745-750.
4CHAN J K,PHAM H,YOU X J,et al.Suppression of ovarian cancer cell tumorigenicity and evasion of cisplatin resistance using a truncated epidermal growth factor receptor in a rat model[J].Cancer Res,2005,65:3243-3248.
5MAIHLE N J,BARON A T,BARRETTE B A,et al.EGF/ErbB receptor family in ovarian cancer[J].Cancer Treat Res,2002,107:247-258.
6WISCHNEWSKI F,PANTEL K,SCHWARZENBACH H,et al.Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1,-A2,-A3,and -A12 in human cancer cells[J].Mol Cancer Res,2006,4(5):339-349.
7PATZEL V,RUTZ S,DIETRICH I,et al.Design of siRNA producing unstructured guide-RNAs results in improved RNA interference efficiency[J].Nat Biotechnol,2005,23(11):1440-1444.
8RAND T A,PETERSEN S,DU F,et al.Argonaute2 cleaves the antiguide strand of siRNA during RISC activation[J].Cell,2005,123(4):621-629.
9NIELSEN J S,JAKOBSEN E,HOLUND B,et al.Prognostic significance of p53,Her-2,and EGFR overexpression in borderline and epithelial ovarian cancer[J].Int J Gynecol Cancer,2004,14(6):1086.
10ALPER O,BERGMANN-LEITNER E S E S,et al.Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells[J].J Natl Cancer Inst,2001,93(18):1375.
